(Q38259510)

1 September 2017

1 reference

title

Vaccine adjuvant uses of poly-IC and derivatives (English)

1 reference

1 September 2017

2

Sina Bavari

1 reference

1 September 2017

Karen A O Martins

1

1 reference

1 September 2017

Andres M Salazar

series ordinal

3

1 reference

1 September 2017

publication date

13 October 2014

1 reference

Expert Review of Vaccines

1 September 2017

published in

1 reference

1 September 2017

volume

14

1 reference

1 September 2017

issue

3

1 reference

1 September 2017

page(s)

447-459

1 reference

Vaccine adjuvants: putting innate immunity to work

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

TLR-based immune adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Immunological mechanisms of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Trends in vaccine adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Key roles of adjuvants in modern vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Mechanism of action of clinically approved adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Immunomodulatory properties of the vaccine adjuvant alum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

The ABC of clinical and experimental adjuvants--a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

CpG DNA as a vaccine adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

New adjuvants for human vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Combinatorial immunotherapy of polyinosinic-polycytidylic acid and blockade of programmed death-ligand 1 induce effective CD8 T-cell responses against established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent manners

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Expression and function of the inducible costimulator ligand B7-H2 in human airway smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Cutting edge: polyinosinic:polycytidylic acid boosts the generation of memory CD8 T cells through melanoma differentiation-associated protein 5 expressed in stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

dsRNA-activation of TLR3 and RLR signaling: gene induction-dependent and independent effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Structural requirements of the rIn·rCn complex for Induction of human interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti–human DEC205 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

TLR3 is essential for the induction of protective immunity against Punta Toro Virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not Poly(I:C): differential recognition of synthetic dsRNA molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Not all polyriboinosinic-polyribocytidylic acids (Poly I:C) are equivalent for inducing maturation of dendritic cells: implication for alpha-type-1 polarized DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Toll-like receptor 3 ligand and retinoic acid enhance germinal center formation and increase the tetanus toxoid vaccine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

ER stress and its regulator X-box-binding protein-1 enhance polyIC-induced innate immune response in dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Poly IC triggers a cathepsin D- and IPS-1-dependent pathway to enhance cytokine production and mediate dendritic cell necroptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

CD141⁺ myeloid dendritic cells are enriched in healthy human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+ dendritic cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Type I interferons keep activated T cells alive

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Type I IFN substitutes for T cell help during viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Pattern-recognition receptor signaling regulator mRNA expression in humans and mice, and in transient inflammation or progressive fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Genomic responses in mouse models poorly mimic human inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Of mice and not men: differences between mouse and human immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Mouse CD11c(+) B220(+) Gr1(+) plasmacytoid dendritic cells develop independently of the T-cell lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Species-specific regulation of Toll-like receptor 3 genes in men and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Length of dsRNA (poly I:C) drives distinct innate immune responses, depending on the cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

A misaligned double-stranded RNA, poly(I).poly(C12,U), induces accumulation of 2',5'-oligoadenylates in mouse tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

A clinical grade poly I:C-analogue (Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Interferon Induction in Cynomolgus and Rhesus Monkeys After Repeated Doses of a Modified Polyriboinosinic-Polyribocytidylic Acid Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Breakthrough of the year 2013. Cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander".

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Polyinosinic-polycytidylic acid is the most effective TLR adjuvant for SIV Gag protein-induced T cell responses in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Swine Influenza Virus Vaccine: Potentiation of Antibody Responses in Rhesus Monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Intranasal administration of adjuvant-combined vaccine protects monkeys from challenge with the highly pathogenic influenza A H5N1 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I·C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Mismatched double-stranded RNA, ampligen (poly(I) : poly(C12U)), demonstrates antiviral and immunostimulatory activities in HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Mismatched double-stranded RNA (ampligen) reduces concentration of zidovudine (azidothymidine) required for in-vitro inhibition of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Inhibition of HIV-1 proviral DNA synthesis and RNA accumulation by mismatched dsRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Mismatched dsRNA (ampligen) induces protection against genomic variants of the human immunodeficiency virus type 1 (HIV-1) in a multiplicity of target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Intranasal administration of dsRNA analog poly(I:C) induces interferon-α receptor-dependent accumulation of antigen experienced T cells in the airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

TLR ligands differentially affect uptake and presentation of cellular antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

TLR signalling regulated antigen presentation in dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Particulate vaccines: on the quest for optimal delivery and immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Nanoparticles target distinct dendritic cell populations according to their size

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

The impact of nanoparticle ligand density on dendritic-cell targeted vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Biodegradable particles as vaccine delivery systems: size matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Combination adjuvants: the next generation of adjuvants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

A comparative study of the antigen-specific immune response induced by co-delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Liposome-mediated immunotherapy against respiratory influenza virus infection using double-stranded RNA poly ICLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Modulation of T-cell function by type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

poly(I:C) and LPS induce distinct IRF3 and NF-κB signaling during type-I IFN and TNF responses in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

Prophylactic, therapeutic and immune enhancement effect of liposome-encapsulated PolyICLC on highly pathogenic H5N1 influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.966085

10.1586/14760584.2015.966085

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference